Episode description:
Moderator:
Tanja Obradovic, PhD, Vice President, Medical & Scientific Strategy, Oncology, Novotech
Guests:
Jiamin Zhuo, Cofounder of ISWT community, and Director, Global Strategy Insight at EMD Serono
Renita Hite, Director Regulatory, Novotech
Where can APAC add the most value to your oncology program?
Join experts to explore:
Market selection: Evaluating Australia, China, Korea, Japan and other APAC markets to determine where the region can add the most value to an oncology program.
Global development strategy: Designing early clinical programs to generate evidence that supports global development objectives and enhances asset value.
Regulatory considerations: Exploring evolving regulatory pathways that may facilitate APAC integration into global programs and key considerations for navigating regional requirements.
This podcast episode was adapted from a previously recorded webinar.





